Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about Beckley Psytech Recent news which mentions Beckley Psytech Beckley Psytech Doses First Patients With Psilocin In Trial For Treatment Of Major Depression Disorder June 20, 2024 Tickers NEWS Tags Market News Cannabis Beckley Psytech From Benzinga Imperial College Scientists Dose First Patient With 5-MeO-DMT To Examine One Of The Most Potent Psychedelics' Effects On The Brain June 03, 2024 Tickers NEWS Tags Benzinga Psychedelics Christopher Timmermann From Benzinga First Patient Dosed In Psychedelics Therapy Study For Treatment-Resistant Depression April 26, 2024 Tickers NEWS Tags Beckley Psytech 5/MeO/DMT Cannabis From Benzinga UK-Based Approach To Alcohol Addiction: 5-MeO-DMT Candidate Moves To Phase 2 Clinical Stage April 05, 2023 Tags News alcohol use disorder Benzinga From Benzinga Phase 2 Trial For This Psychedelic, Potential Treatment For Severe Depression December 22, 2022 Tags Market News Cannabis Markets From Benzinga Beyond Magic Mushrooms: Positive Clinical Trial For Treatment-Resistant Depression & Alcoholism November 16, 2022 Tags Psychedelics Benzinga News From Benzinga Psychedelics M&A: Beckley Psytech Acquires Eleusis Therapeutics, Strengthening Drug Pipeline And R&D Team October 24, 2022 Tags Cosmo Feilding Mellen Psychedelics Benzinga From Benzinga Palo Santo Closes $50M Psychedelic Therapeutics Investment Fund October 12, 2022 Tags Cosmo Feilding Mellen Multidisciplinary Association for Psychedelic Studies Financing From Benzinga Beckley Psytech Begins Training Therapists For Phase 2 Trial With Toad Venom, 5-MeO-DMT January 24, 2022 Tags Benzinga psychedelics News From Benzinga Psyched: Beckley Psytech Raises $80M, Diamond Therapeutics To Study Psilocybin Microdosing, Mydecine and Johns Hopkins Partner Up August 23, 2021 Tickers CLABF MYCOF SILFF Tags Cosmo Feilding Mellen Benzinga Diamond Therapeutics Inc/ From Benzinga Beckley Psytech Reaches $100M Financing To Study 5-MeO-DMT, Psilocybin And Other Psychedelics August 19, 2021 Tags psychedelics Cannabis Market News From Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.